ArticleBMJ open2024

Protocol for a mixed-methods study to develop and feasibility test a digital system for the capture of patient-reported outcomes (PROs) in patients receiving chimeric antigen receptor T-cell (CAR-T) therapies (the PRO-CAR-T study).

Sarah E Hughes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.